Requirements Definition Document (RDD)
|
|
- Phyllis Lester
- 6 years ago
- Views:
Transcription
1 Requirements Definition Document (RDD) Revision History Date Version Created By/Revised By: Reason for Revision: 20 Jan Tauhid Siddiqui 27 Jan Tauhid Siddiqui Incorporating changes suggested by Oracle Version <1.0> Page 1 of 24
2 Prepared By CDS: Signature: Name: Tauhid Siddiqui Title: PL Date: 27 Jan 2012 Accepted And Agreed By DMS: Signature: Name: Title: Date: CDS PM Approval: Signature: Name: Title: Date: Version <1.0> Page 2 of 24
3 Table of Contents 1 Document Overview Abbreviations and Acronyms Introduction RID 1 Specified Configuration Settings RID 2 List of Visits RID 3 List of Lab Forms RID 4 List of Lab Tests RID 5 IIE-LNMT Configuration Version <1.0> Page 3 of 24
4 1 Document Overview This Requirements Definition Document (RDD) details the requirements, defined by DMS, to allow the LNMT 4.0 Solution to be properly implemented and configured for the study. Once this document has been finalized and approved, it will be utilized to implement the solution. 2 Abbreviations and Acronyms This is a list of definitions of specific technical and functional terms and concepts that may be used in this and other documents relating to this system. Item Definition LNMT Lab Normal Management Tool LNR Lab Normal Range ecrf Electronic Case Record Form InForm Oracle s Web-based Electronic Data Capture solution N/A Not Applicable Pdf Portable Document File RDD Requirements Definition Document RID Requirements Identifier SOW Statement of Work 3 Introduction The following sections of this document capture the necessary specific requirements to properly implement and configure the LNMT 4.0 solution. Each requirement is identified via a Requirements Identifier (RID) for traceability purposes. Version <1.0> Page 4 of 24
5 RID 1 Specified Configuration Settings LNMT CONFIGURATION SETTINGS ITEM STANDARD /DEFAULT DMS SPECIFIED Security Rights Group for Lab Vendor Data entry access <AllowedGroups></AllowedGroups> (Allows Add/Edit/Delete on Lab Vendor page) Security Rights Group for LNR Data entry access <LNRDataEntryGroups></LNRDataEntryGroups> (Allows Add/Edit/Delete on LNR page) Security Rights Group for LNMT Read Only Access <ReadOnlyGroups></ReadOnlyGroups> (Allows Read only access on Lab Vendor and Lab Normal page) Security Rights Group for LNMT Admin Access <AdminGroups></AdminGroups> (Allows mapping InForm Lab Form controls and InForm Demographic controls with LNMT) Security Rights Group for viewing Audit Reports Access <ViewAuditReportGroups></ViewAuditReportGroups> (Allows access to view complete Audit of Lab Vendor and LNR entries in LNMT) LNMT Refresh Interval 15 minutes Sponsor Data Entry,PI,CRC, System Creator Group Sponsor Data Entry,PI,CRC, System Creator Group GDMS,Project Manager,Developer,Medical Monitor,Safety Specialist,CRA,PIsig,Support,Vendor View Only Developer,Support, System Creator Group GDMS,Project Manager,Developer,Medical Monitor,Safety Specialist,CRA,Support,Vendor View Only Version <1.0> Page 5 of 24
6 RID 2 List of Visits VISIT MNEMONIC Example: UNSCHED Visit 1 Visit 2 Visit 4 Visit 5 Visit 6 Unscheduled REPEATING VISIT S REF NAME (CASE SENSITIVE) TO BE COMPLETED DURING IMPLEMENTATION VISIT1 VISIT2 VISIT4 VISIT5 VISIT6 UNSCHED Version <1.0> Page 6 of 24
7 RID 3 List of Lab Forms LAB Form (FORM MNEMONICS) Example: CLB01 CLB01 CLB01A HLB01 HLB01A OLB01 ULB01 ULB01A REPEATING FORM REF NAME (CASE SENSITIVE) TO BE COMPLETED DURING IMPLEMENTATION CLB01FM CLB01AFM HLB01FM HLB01AFM OLB01FM ULB01FM ULB01AFM Version <1.0> Page 7 of 24
8 RID 4 List of Lab Tests LAB TEST UNITS LNMT ITEMS REF PATH (FROM SECTION ONWARDS) TO BE COMPLETED DURING IMPLEMENTATION Example: RBC 10^12/L, DisplayString scthema2.0.itmlymphlnmt.gclymphlnmt.tclymphlnmtrng cells/l, cells/mm^3 scthema2.0.itmlymphlnmt.gclymphlnmt.tclymphlnmtflag LAB TEST UNITS REF PATH <!--CLB01AFM--> Total Bilirubin Total Protein Uric Acid Urea Carbon Dioxide Creatine Kinase Indirect Bilirubin Triglycerides <!--CLB01FM--> mg/dl,mmol/l,g/dl,mg%,u mol/l,mg/l gm/dl,g/l,g%,mg/dl mg/dl,mmol/l,umol/l,nmo l/l,mg/l,mg% gm/l,mg/dl,mmol/l,mg% meq/l,mmol/l IU/L,mIU/mL,microkat/L gm/dl,mg/dl,mmol/l,micr omol/l,mg/l,mg% mg/dl,mmol/l,mg% DisplayString CLB01ARSLTSN.0.CL1ALBORNRTBUIT.CL1ALBORNRTBUGC.CL1ALBORNRTBUTB CLB01ARSLTSN.0.CL1ALBORNRTBUIT.CL1ALBORNRTBUGC.CL1ALBINRANGETBTB DisplayString CLB01ARSLTSN.0.CL1ALBORNRTPUIT.CL1ALBORNRTPUGC.CL1ALBORNRTPUTB CLB01ARSLTSN.0.CL1ALBORNRTPUIT.CL1ALBORNRTPUGC.CL1ALBRANGETPTB DisplayString CLB01ARSLTSN.0.CL1ALBORNRUAUIT.CL1ALBORNRUAUGC.CL1ALBORNRUAUTB CLB01ARSLTSN.0.CL1ALBORNRUAUIT.CL1ALBORNRUAUGC.CL1ALBINRANGEUATB DisplayString CLB01ARSLTSN.0.CL1ALBORNRURUIT.CL1ALBORNRURUGC.CL1ALBORNRURUTB CLB01ARSLTSN.0.CL1ALBORNRURUIT.CL1ALBORNRURUGC.CL1ALBINRANGEURTB DisplayString CLB01ARSLTSN.0.CL1ALBORNRUCDIT.CL1ALBORNRUCDGC.CL1ALBORNRUCDTB CLB01ARSLTSN.0.CL1ALBORNRUCDIT.CL1ALBORNRUCDGC.CL1ALBINRANGECDTB DisplayString CLB01ARSLTSN.0.CL1ALBORNRUCKIT.CL1ALBORNRUCKGC.CL1ALBORNRUCKTB CLB01ARSLTSN.0.CL1ALBORNRUCKIT.CL1ALBORNRUCKGC.CL1ALBINRANGECKTB DisplayString CLB01ARSLTSN.0.CL1ALBORNRUIBIT.CL1ALBORNRUIBGC.CL1ALBORNRUIBTB CLB01ARSLTSN.0.CL1ALBORNRUIBIT.CL1ALBORNRUIBGC.CL1ALBINRANGEIBTB DisplayString CLB01ARSLTSN.0.CL1ALBORNRUTGIT.CL1ALBORNRUTGGC.CL1ALBORNRUTGTB CLB01ARSLTSN.0.CL1ALBORNRUTGIT.CL1ALBORNRUTGGC.CL1ALBINRANGETGTB Version <1.0> Page 8 of 24
9 Albumin Alkaline Phosphatase ALT (Alanine Aminotransferase) Amylase AST (Aspartate Aminotransferase) Bicarbonate Blood Urea Nitrogen Calcium Chloride Cholesterol Creatinine Direct Bilirubin Gamma-GT (Gamma- Glutamyl Transpeptidase) Gluclose LDH (Lactate g/dl,umol/dl,umol/l,g/l,%,g%,mg/dl,mmol/l IU/L,IU/dL,ukat/L,mIU/m L,umol/L/sec,umol/L/min IU/L,IU/dL,ukat/L,mIU/m L,umol/L/sec,umol/L/min IU/L,IU/dL,microkat/L,m IU/mL IU/L,IU/dL,ukat/L,mIU/m L,umol/L/sec,umol/L/min mmol/l,meq/l,mg/dl mg/dl,iu/l,mmol/l,mg%,g /L mg/dl,mmol/l,meq/l,mg%, mg/l mmol/l,mg/dl,mmol/dl,me q/ml,meq/l mg/dl,mmol/l,mg% mg/dl,mmol/l,meq/l,umol /dl,umol/l,mg/l,mg% mg/dl,mmol/l,g/dl,mg%,u mol/l,mg/l IU/L,mIU/mL,ukat/L mg/dl,mmol/l,mmol/dl,g/ dl,mg/ml,mg% DisplayString CLB01RSLTSN.0.CL1LBORNRALUIT.CL1LBORNRALUGC.CL1LBORNRALUTB CLB01RSLTSN.0.CL1LBORNRALUIT.CL1LBORNRALUGC.CL1LBINRANGEALTB DisplayString CLB01RSLTSN.0.CL1LBORNRAPUIT.CL1LBORNRAPUGC.CL1LBORNRAPUTB CLB01RSLTSN.0.CL1LBORNRAPUIT.CL1LBORNRAPUGC.CL1LBINRANGEAPTB DisplayString CLB01RSLTSN.0.CL1LBORNRATUIT.CL1LBORNRATUGC.CL1LBORNRATUTB CLB01RSLTSN.0.CL1LBORNRATUIT.CL1LBORNRATUGC.CL1LBINRANGEATTB DisplayString CLB01RSLTSN.0.CL1LBORNRAMUIT.CL1LBORNRAMUGC.CL1LBORNRAMUTB CLB01RSLTSN.0.CL1LBORNRAMUIT.CL1LBORNRAMUGC.CL1LBINRANGEAMTB DisplayString CLB01RSLTSN.0.CL1LBORNRASUIT.CL1LBORNRASUGC.CL1LBORNRASUTB CLB01RSLTSN.0.CL1LBORNRASUIT.CL1LBORNRASUGC.CL1LBINRANGEASTB DisplayString CLB01RSLTSN.0.CL1LBORNRBIUIT.CL1LBORNRBIUGC.CL1LBORNRBIUTB CLB01RSLTSN.0.CL1LBORNRBIUIT.CL1LBORNRBIUGC.CL1LBINRANGEBITB DisplayString CLB01RSLTSN.0.CL1LBORNRBUUIT.CL1LBORNRBUUGC.CL1LBORNRBUUTB CLB01RSLTSN.0.CL1LBORNRBUUIT.CL1LBORNRBUUGC.CL1LBINRANGEBUTB DisplayString CLB01RSLTSN.0.CL1LBORNRCAUIT.CL1LBORNRCAUGC.CL1LBORNRCAUTB CLB01RSLTSN.0.CL1LBORNRCAUIT.CL1LBORNRCAUGC.CL1LBINRANGECATB DisplayString CLB01RSLTSN.0.CL1LBORNRCLUIT.CL1LBORNRCLUGC.CL1LBORNRCLUTB CLB01RSLTSN.0.CL1LBORNRCLUIT.CL1LBORNRCLUGC.CL1LBINRANGECLTB DisplayString CLB01RSLTSN.0.CL1LBORNRCHUIT.CL1LBORNRCHUGC.CL1LBORNRCHUTB CLB01RSLTSN.0.CL1LBORNRCHUIT.CL1LBORNRCHUGC.CL1LBINRANGECHTB DisplayString CLB01RSLTSN.0.CL1LBORNRCRUIT.CL1LBORNRCRUGC.CL1LBORNRCRUTB CLB01RSLTSN.0.CL1LBORNRCRUIT.CL1LBORNRCRUGC.CL1LBINRANGECRTB DisplayString CLB01RSLTSN.0.CL1LBORNRDBUIT.CL1LBORNRDBUGC.CL1LBORNRDBUTB CLB01RSLTSN.0.CL1LBORNRDBUIT.CL1LBORNRDBUGC.CL1LBINRANGEDBTB DisplayString CLB01RSLTSN.0.CL1LBORNRGTUIT.CL1LBORNRGTUGC.CL1LBORNRGTUTB CLB01RSLTSN.0.CL1LBORNRGTUIT.CL1LBORNRGTUGC.CL1LBINRANGEGTTB DisplayString CLB01RSLTSN.0.CL1LBORNRGLUIT.CL1LBORNRGLUGC.CL1LBORNRGLUTB CLB01RSLTSN.0.CL1LBORNRGLUIT.CL1LBORNRGLUGC.CL1LBINRANGEGLTB IU/L,IU/dL,mIU/mL,ukat/ DisplayString CLB01RSLTSN.0.CL1LBORNRLDUIT.CL1LBORNRLDUGC.CL1LBORNRLDUTB Version <1.0> Page 9 of 24
10 Dehydrogenase) L Lipase Magnesium Phosphorus Potassium Sodium <!--HLB01AFM--> Blasts Blasts/Leukocytes % White Blood Cell Count Red Blood Cell Count Hemoglobin Hematocrit Leukemic Blasts Leukemic Blasts/Lymphocytes % IU/L,IU/dL,microkat/L meq/l,mg/dl,mg/l,mmol/l meq/l,mg/dl,mg/l,mg%,mm ol/l meq/l,mg/dl,mmol/l mmol/l,meq/l,mg/dl /mm[3],/nl,/ul,10[3]/mm [3],10[3]/uL,10[9]/L 10[2]/uL,/nL,/uL,/mm[3],10[3]uL,10[3]/mm[3],10 [9]/L 10[3]/uL,10[3]/mm[3],10 [4]/mm[3],10[4]/uL,10[6 ]/mm[3],10[6]/ul,10[9]/ L,10[12]/L,/uL g/dl,g/l,mg/dl,mmol/l,g m% %,ratio,l/l,volume fraction,g/dl,ml/dl /mm[3],/nl,/ul,10[3]/mm [3],10[3]/uL,10[9]/L CLB01RSLTSN.0.CL1LBORNRLDUIT.CL1LBORNRLDUGC.CL1LBINRANGELDTB DisplayString CLB01RSLTSN.0.CL1LBORNRLIUIT.CL1LBORNRLIUGC.CL1LBORNRLIUTB CLB01RSLTSN.0.CL1LBORNRLIUIT.CL1LBORNRLIUGC.CL1LBINRANGELITB DisplayString CLB01RSLTSN.0.CL1LBORNRMAUIT.CL1LBORNRMAUGC.CL1LBORNRMAUTB CLB01RSLTSN.0.CL1LBORNRMAUIT.CL1LBORNRMAUGC.CL1LBINRANGEMATB DisplayString CLB01RSLTSN.0.CL1LBORNRPHUIT.CL1LBORNRPHUGC.CL1LBORNRPHUTB CLB01RSLTSN.0.CL1LBORNRPHUIT.CL1LBORNRPHUGC.CL1LBINRANGEPHTB DisplayString CLB01RSLTSN.0.CL1LBORNRPOUIT.CL1LBORNRPOUGC.CL1LBORNRPOUTB CLB01RSLTSN.0.CL1LBORNRPOUIT.CL1LBORNRPOUGC.CL1LBINRANGEPOTB DisplayString CLB01RSLTSN.0.CL1LBORNRSOUIT.CL1LBORNRSOUGC.CL1LBORNRSOUTB CLB01RSLTSN.0.CL1LBORNRSOUIT.CL1LBORNRSOUGC.CL1LBINRANGESOTB DisplayString HLB01ARESSN.0.HL1ALBORNRBLUIT.HL1ALBORNRBLUGC.HL1ALBORNRBLUTB HLB01ARESSN.0.HL1ALBORNRBLUIT.HL1ALBORNRBLUGC.HL1ALBINRANGEBLTB DisplayString HLB01ARESSN.0.HL1ALBORNRBKUIT.HL1ALBORNRBKUGC.HL1ALBORNRBKUTB HLB01ARESSN.0.HL1ALBORNRBKUIT.HL1ALBORNRBKUGC.HL1ALBINRANGEBKTB DisplayString HLB01ARESSN.0.HL1ALBORNRFPUIT.HL1ALBORNRFPUGC.HL1ALBORNRFPUTB HLB01ARESSN.0.HL1ALBORNRFPUIT.HL1ALBORNRFPUGC.HL1ALBINRANGEFPTB DisplayString HLB01ARESSN.0.HL1ALBORNRRBUIT.HL1ALBORNRRBUGC.HL1ALBORNRRBUTB HLB01ARESSN.0.HL1ALBORNRRBUIT.HL1ALBORNRRBUGC.HL1ALBINRANGERBTB DisplayString HLB01ARESSN.0.HL1ALBORNRHGUIT.HL1ALBORNRHGUGC.HL1ALBORNRHGUTB HLB01ARESSN.0.HL1ALBORNRHGUIT.HL1ALBORNRHGUGC.HL1ALBINRANGEHGTB DisplayString HLB01ARESSN.0.HL1ALBORNRHCUIT.HL1ALBORNRHCUGC.HL1ALBORNRHCUTB HLB01ARESSN.0.HL1ALBORNRHCUIT.HL1ALBORNRHCUGC.HL1ALBINRANGEHCTB DisplayString HLB01ARESSN.0.HL1ALBORNRLBUIT.HL1ALBORNRLBUGC.HL1ALBORNRLBUTB HLB01ARESSN.0.HL1ALBORNRLBUIT.HL1ALBORNRLBUGC.HL1ALBINRANGELBTB DisplayString HLB01ARESSN.0.HL1ALBORNRLLUIT.HL1ALBORNRLLUGC.HL1ALBORNRLLUTB HLB01ARESSN.0.HL1ALBORNRLLUIT.HL1ALBORNRLLUGC.HL1ALBINRANGELLTB Version <1.0> Page 10 of 24
11 MCV MCH MCHC Metamyelocyte Count Metamyelocyte Count/Leukocytes % Monoblasts Monoblasts/Leukocyt es % Myeloblasts Myeloblasts/Leukocy tes % Promyelocytes Promyelocytes/Leuko cytes % fl,mm[3],micron[3],/mic rol fmol/cell,pg/cell g/dl,%,g/l,gm%,mmol/l /mm[3],/nl,/ul,10[3]/mm [3],10[3]/uL,10[9]/L /mm[3],/nl,/ul,10[3]/mm [3],10[3]/uL,10[9]/L /mm3,/nl,/ul,10[3]/mm[3 ],10[3]/uL,10[9]/L /mm[3],/nl,/ul,10[3]/mm [3],10[3]/uL,10[9]/L RDW % /mm[3],10[3]/mm[3],10[4 ]/mm[3],/nl,/ul,10[3]/u L,10[4]/uL,10[9]/L,10[1 Platelet Count 2]/L Absolute Neutrophil /ul,/mm[3],10[3]/mm[3], 10[9]/L,10[3]/uL,/nL DisplayString HLB01ARESSN.0.HL1ALBORNRMCUIT.HL1ALBORNRMCUGC.HL1ALBORNRMCUTB HLB01ARESSN.0.HL1ALBORNRMCUIT.HL1ALBORNRMCUGC.HL1ALBINRANGEMCTB DisplayString HLB01ARESSN.0.HL1ALBORNRMHUIT.HL1ALBORNRMHUGC.HL1ALBORNRMHUTB HLB01ARESSN.0.HL1ALBORNRMHUIT.HL1ALBORNRMHUGC.HL1ALBINRANGEMHTB DisplayString HLB01ARESSN.0.HL1ALBORNRCHUIT.HL1ALBORNRCHUGC.HL1ALBORNRCHUTB HLB01ARESSN.0.HL1ALBORNRCHUIT.HL1ALBORNRCHUGC.HL1ALBINRANGECHTB DisplayString HLB01ARESSN.0.HL1ALBORNRMLUIT.HL1ALBORNRMLUGC.HL1ALBORNRMLUTB HLB01ARESSN.0.HL1ALBORNRMLUIT.HL1ALBORNRMLUGC.HL1ALBINRANGEMLTB DisplayString HLB01ARESSN.0.HL1ALBORNRMKUIT.HL1ALBORNRMKUGC.HL1ALBORNRMKUTB HLB01ARESSN.0.HL1ALBORNRMKUIT.HL1ALBORNRMKUGC.HL1ALBINRANGEMKTB DisplayString HLB01ARESSN.0.HL1ALBORNRMBUIT.HL1ALBORNRMBUGC.HL1ALBORNRMBUTB HLB01ARESSN.0.HL1ALBORNRMBUIT.HL1ALBORNRMBUGC.HL1ALBINRANGEMBTB DisplayString HLB01ARESSN.0.HL1ALBORNRMNUIT.HL1ALBORNRMNUGC.HL1ALBORNRMNUTB HLB01ARESSN.0.HL1ALBORNRMNUIT.HL1ALBORNRMNUGC.HL1ALBINRANGEMNTB DisplayString HLB01ARESSN.0.HL1ALBORNRMYUIT.HL1ALBORNRMYUGC.HL1ALBORNRMYUTB HLB01ARESSN.0.HL1ALBORNRMYUIT.HL1ALBORNRMYUGC.HL1ALBINRANGEMYTB DisplayString HLB01ARESSN.0.HL1ALBORNRMEUIT.HL1ALBORNRMEUGC.HL1ALBORNRMEUTB HLB01ARESSN.0.HL1ALBORNRMEUIT.HL1ALBORNRMEUGC.HL1ALBINRANGEMETB DisplayString HLB01ARESSN.0.HL1ALBORNRPMUIT.HL1ALBORNRPMUGC.HL1ALBORNRPMUTB HLB01ARESSN.0.HL1ALBORNRPMUIT.HL1ALBORNRPMUGC.HL1ALBINRANGEPMTB DisplayString HLB01ARESSN.0.HL1ALBORNRPLUIT.HL1ALBORNRPLUGC.HL1ALBORNRPLUTB HLB01ARESSN.0.HL1ALBORNRPLUIT.HL1ALBORNRPLUGC.HL1ALBINRANGEPLTB DisplayString HLB01ARESSN.0.HL1ALBORNRRWUIT.HL1ALBORNRRWUGC.HL1ALBORNRRWUTB HLB01ARESSN.0.HL1ALBORNRRWUIT.HL1ALBORNRRWUGC.HL1ALBINRANGERWTB DisplayString HLB01ARESSN.0.HL1ALBORNRPCUIT.HL1ALBORNRPCUGC.HL1ALBORNRPCUTB HLB01ARESSN.0.HL1ALBORNRPCUIT.HL1ALBORNRPCUGC.HL1ALBINRANGEPCTB DisplayString HLB01AWBCDSN.0.HL1ALBORNRANUIT.HL1ALBORNRANUGC.HL1ALBORNRANUTB HLB01AWBCDSN.0.HL1ALBORNRANUIT.HL1ALBORNRANUGC.HL1ALBINRANGEANTB Version <1.0> Page 11 of 24
12 Absolute Band Neutrophil Absolute Lymphocyte Absolute Monocyte Absolute Eosinophil Absolute Basophil Absolute Atypical Lymphocyte /ul,/mm[3],10[3]/mm[3], 10[9]/L,10[3]/uL,/nL /ul,/mm[3],10[3]/mm[3], 10[9]/L,10[3]/uL,/nL /ul,/mm[3],10[3]/mm[3], 10[9]/L,10[3]/uL,/nL /ul,/mm[3],10[3]/mm[3], 10[9]/L,10[3]/uL,/nL /ul,/mm[3],10[3]/mm[3], 10[9]/L,10[3]/uL,/nL /ul,/mm[3],10[3]/mm[3], 10[9]/L,10[3]/uL,/nL Prothrombin Time seconds,%,ratio (/) INR n/a Activated Partial Thromboplastin Time seconds,ratio (/) <!--HLB01FM--> Blasts Blasts/Leukocytes % White Blood Cell Count Red Blood Cell Count Hemoglobin /mm[3],/nl,/ul,10[3]/mm [3],10[3]/uL,10[9]/L 10[2]/uL,/nL,/uL,/mm[3],10[3]uL,10[3]/mm[3],10 [9]/L 10[3]/uL,10[3]/mm[3],10 [4]/mm[3],10[4]/uL,10[6 ]/mm[3],10[6]/ul,10[9]/ L,10[12]/L,/uL DisplayString HLB01AWBCDSN.0.HL1ALBORNRBNUIT.HL1ALBORNRBNUGC.HL1ALBORNRBNUTB HLB01AWBCDSN.0.HL1ALBORNRBNUIT.HL1ALBORNRBNUGC.HL1ALBINRANGEBNTB DisplayString HLB01AWBCDSN.0.HL1ALBORNRALUIT.HL1ALBORNRALUGC.HL1ALBORNRALUTB HLB01AWBCDSN.0.HL1ALBORNRALUIT.HL1ALBORNRALUGC.HL1ALBINRANGEALTB DisplayString HLB01AWBCDSN.0.HL1ALBORNRAMUIT.HL1ALBORNRAMUGC.HL1ALBORNRAMUTB HLB01AWBCDSN.0.HL1ALBORNRAMUIT.HL1ALBORNRAMUGC.HL1ALBINRANGEAMTB DisplayString HLB01AWBCDSN.0.HL1ALBORNRAEUIT.HL1ALBORNRAEUGC.HL1ALBORNRAEUTB HLB01AWBCDSN.0.HL1ALBORNRAEUIT.HL1ALBORNRAEUGC.HL1ALBINRANGEAETB DisplayString HLB01AWBCDSN.0.HL1ALBORNRABUIT.HL1ALBORNRABUGC.HL1ALBORNRABUTB HLB01AWBCDSN.0.HL1ALBORNRABUIT.HL1ALBORNRABUGC.HL1ALBINRANGEABTB DisplayString HLB01AWBCDSN.0.HL1ALBORNRTLUIT.HL1ALBORNRTLUGC.HL1ALBORNRTLUTB HLB01AWBCDSN.0.HL1ALBORNRTLUIT.HL1ALBORNRTLUGC.HL1ALBINRANGETLTB DisplayString HLB01AHTSN.0.HL1ALBORNRPTUIT.HL1ALBORNRPTUGC.HL1ALBORNRPTUTB HLB01AHTSN.0.HL1ALBORNRPTUIT.HL1ALBORNRPTUGC.HL1ALBINRANGEPTTB DisplayString HLB01AHTSN.0.HL1ALBORNRIRUIT.HL1ALBORNRIRUGC.HL1ALBORNRIRUTB HLB01AHTSN.0.HL1ALBORNRIRUIT.HL1ALBORNRIRUGC.HL1ALBINRANGEIRTB DisplayString HLB01AHTSN.0.HL1ALBORNRIAPIT.HL1ALBORNRIAPGC.HL1ALBORNRIAPTB HLB01AHTSN.0.HL1ALBORNRIAPIT.HL1ALBORNRIAPGC.HL1ALBINRANGEAPTB DisplayString HLB01RESSN.0.HL1LBORNRBLUIT.HL1LBORNRBLUGC.HL1LBORNRBLUTB HLB01RESSN.0.HL1LBORNRBLUIT.HL1LBORNRBLUGC.HL1LBINRANGEBLTB DisplayString HLB01RESSN.0.HL1LBORNRBKUIT.HL1LBORNRBKUGC.HL1LBORNRBKUTB HLB01RESSN.0.HL1LBORNRBKUIT.HL1LBORNRBKUGC.HL1LBINRANGEBKTB DisplayString HLB01RESSN.0.HL1LBORNRFPUIT.HL1LBORNRFPUGC.HL1LBORNRFPUTB HLB01RESSN.0.HL1LBORNRFPUIT.HL1LBORNRFPUGC.HL1LBINRANGEFPTB DisplayString HLB01RESSN.0.HL1LBORNRRBUIT.HL1LBORNRRBUGC.HL1LBORNRRBUTB HLB01RESSN.0.HL1LBORNRRBUIT.HL1LBORNRRBUGC.HL1LBINRANGERBTB g/dl,g/l,mg/dl,mmol/l,g DisplayString HLB01RESSN.0.HL1LBORNRHGUIT.HL1LBORNRHGUGC.HL1LBORNRHGUTB Version <1.0> Page 12 of 24
13 m% Hematocrit Leukemic Blasts Leukemic Blasts/Lymphocytes % MCV MCH MCHC Metamyelocyte Count Metamyelocyte Count/Leukocytes % Monoblasts Monoblasts/Leukocyt es % Myeloblasts Myeloblasts/Leukocy tes % Promyelocytes Promyelocytes/Leuko cytes % %,ratio,l/l,volume fraction,g/dl,ml/dl /mm[3],/nl,/ul,10[3]/mm [3],10[3]/uL,10[9]/L fl,mm[3],micron[3],/mic rol fmol/cell,pg/cell g/dl,%,g/l,gm%,mmol/l /mm[3],/nl,/ul,10[3]/mm [3],10[3]/uL,10[9]/L /mm[3],/nl,/ul,10[3]/mm [3],10[3]/uL,10[9]/L /mm3,/nl,/ul,10[3]/mm[3 ],10[3]/uL,10[9]/L /mm[3],/nl,/ul,10[3]/mm [3],10[3]/uL,10[9]/L HLB01RESSN.0.HL1LBORNRHGUIT.HL1LBORNRHGUGC.HL1LBINRANGEHGTB DisplayString HLB01RESSN.0.HL1LBORNRHCUIT.HL1LBORNRHCUGC.HL1LBORNRHCUTB HLB01RESSN.0.HL1LBORNRHCUIT.HL1LBORNRHCUGC.HL1LBINRANGEHCTB DisplayString HLB01RESSN.0.HL1LBORNRLBUIT.HL1LBORNRLBUGC.HL1LBORNRLBUTB HLB01RESSN.0.HL1LBORNRLBUIT.HL1LBORNRLBUGC.HL1LBINRANGELBTB DisplayString HLB01RESSN.0.HL1LBORNRLLUIT.HL1LBORNRLLUGC.HL1LBORNRLLUTB HLB01RESSN.0.HL1LBORNRLLUIT.HL1LBORNRLLUGC.HL1LBINRANGELLTB DisplayString HLB01RESSN.0.HL1LBORNRMCUIT.HL1LBORNRMCUGC.HL1LBORNRMCUTB HLB01RESSN.0.HL1LBORNRMCUIT.HL1LBORNRMCUGC.HL1LBINRANGEMCTB DisplayString HLB01RESSN.0.HL1LBORNRMHUIT.HL1LBORNRMHUGC.HL1LBORNRMHUTB HLB01RESSN.0.HL1LBORNRMHUIT.HL1LBORNRMHUGC.HL1LBINRANGEMHTB DisplayString HLB01RESSN.0.HL1LBORNRCHUIT.HL1LBORNRCHUGC.HL1LBORNRCHUTB HLB01RESSN.0.HL1LBORNRCHUIT.HL1LBORNRCHUGC.HL1LBINRANGECHTB DisplayString HLB01RESSN.0.HL1LBORNRMLUIT.HL1LBORNRMLUGC.HL1LBORNRMLUTB HLB01RESSN.0.HL1LBORNRMLUIT.HL1LBORNRMLUGC.HL1LBINRANGEMLTB DisplayString HLB01RESSN.0.HL1LBORNRMKUIT.HL1LBORNRMKUGC.HL1LBORNRMKUTB HLB01RESSN.0.HL1LBORNRMKUIT.HL1LBORNRMKUGC.HL1LBINRANGEMKTB DisplayString HLB01RESSN.0.HL1LBORNRMBUIT.HL1LBORNRMBUGC.HL1LBORNRMBUTB HLB01RESSN.0.HL1LBORNRMBUIT.HL1LBORNRMBUGC.HL1LBINRANGEMBTB DisplayString HLB01RESSN.0.HL1LBORNRMNUIT.HL1LBORNRMNUGC.HL1LBORNRMNUTB HLB01RESSN.0.HL1LBORNRMNUIT.HL1LBORNRMNUGC.HL1LBINRANGEMNTB DisplayString HLB01RESSN.0.HL1LBORNRMYUIT.HL1LBORNRMYUGC.HL1LBORNRMYUTB HLB01RESSN.0.HL1LBORNRMYUIT.HL1LBORNRMYUGC.HL1LBINRANGEMYTB DisplayString HLB01RESSN.0.HL1LBORNRMEUIT.HL1LBORNRMEUGC.HL1LBORNRMEUTB HLB01RESSN.0.HL1LBORNRMEUIT.HL1LBORNRMEUGC.HL1LBINRANGEMETB DisplayString HLB01RESSN.0.HL1LBORNRPMUIT.HL1LBORNRPMUGC.HL1LBORNRPMUTB HLB01RESSN.0.HL1LBORNRPMUIT.HL1LBORNRPMUGC.HL1LBINRANGEPMTB DisplayString HLB01RESSN.0.HL1LBORNRPLUIT.HL1LBORNRPLUGC.HL1LBORNRPLUTB HLB01RESSN.0.HL1LBORNRPLUIT.HL1LBORNRPLUGC.HL1LBINRANGEPLTB Version <1.0> Page 13 of 24
14 RDW % /mm[3],10[3]/mm[3],10[4 ]/mm[3],/nl,/ul,10[3]/u L,10[4]/uL,10[9]/L,10[1 Platelet Count 2]/L Neutrophil (%) % Band Neutrophil (%) % Lymphocyte (%) % Monocyte (%) % Eosinophil (%) % Basophil (%) % Atypical Lymphocyte (%) % Prothrombin Time seconds,%,ratio (/) INR n/a Activated Partial Thromboplastin Time seconds,ratio (/) <!--OLB01FM--> 5-HIAA Alpha 2-Antiplasmin % mg/gm(creatinine),micro mol/mmol(creat),microgm /mg(creatinine) DisplayString HLB01RESSN.0.HL1LBORNRRWUIT.HL1LBORNRRWUGC.HL1LBORNRRWUTB HLB01RESSN.0.HL1LBORNRRWUIT.HL1LBORNRRWUGC.HL1LBINRANGERWTB DisplayString HLB01RESSN.0.HL1LBORNRPCUIT.HL1LBORNRPCUGC.HL1LBORNRPCUTB HLB01RESSN.0.HL1LBORNRPCUIT.HL1LBORNRPCUGC.HL1LBINRANGEPCTB DisplayString HLB01WBCDPSN.0.HL1LBORNRNTUIT.HL1LBORNRNTUGC.HL1LBORNRNTUTB HLB01WBCDPSN.0.HL1LBORNRNTUIT.HL1LBORNRNTUGC.HL1LBINRANGENTTB DisplayString HLB01WBCDPSN.0.HL1LBORNRBTUIT.HL1LBORNRBTUGC.HL1LBORNRBTUTB HLB01WBCDPSN.0.HL1LBORNRBTUIT.HL1LBORNRBTUGC.HL1LBINRANGEBTTB DisplayString HLB01WBCDPSN.0.HL1LBORNRLYUIT.HL1LBORNRLYUGC.HL1LBORNRLYUTB HLB01WBCDPSN.0.HL1LBORNRLYUIT.HL1LBORNRLYUGC.HL1LBINRANGELYTB DisplayString HLB01WBCDPSN.0.HL1LBORNRMOUIT.HL1LBORNRMOUGC.HL1LBORNRMOUTB HLB01WBCDPSN.0.HL1LBORNRMOUIT.HL1LBORNRMOUGC.HL1LBINRANGEMOTB DisplayString HLB01WBCDPSN.0.HL1LBORNREOUIT.HL1LBORNREOUGC.HL1LBORNREOUTB HLB01WBCDPSN.0.HL1LBORNREOUIT.HL1LBORNREOUGC.HL1LBINRANGEEOTB DisplayString HLB01WBCDPSN.0.HL1LBORNRBSUIT.HL1LBORNRBSUGC.HL1LBORNRBSUTB HLB01WBCDPSN.0.HL1LBORNRBSUIT.HL1LBORNRBSUGC.HL1LBINRANGEBSTB DisplayString HLB01WBCDPSN.0.HL1LBORNRACUIT.HL1LBORNRACUGC.HL1LBORNRACUTB HLB01WBCDPSN.0.HL1LBORNRACUIT.HL1LBORNRACUGC.HL1LBINRANGEACTB DisplayString HLB01HTSN.0.HL1LBORNRPTUIT.HL1LBORNRPTUGC.HL1LBORNRPTUTB HLB01HTSN.0.HL1LBORNRPTUIT.HL1LBORNRPTUGC.HL1LBINRANGEPTTB DisplayString HLB01HTSN.0.HL1LBORNRIRUIT.HL1LBORNRIRUGC.HL1LBORNRIRUTB HLB01HTSN.0.HL1LBORNRIRUIT.HL1LBORNRIRUGC.HL1LBINRANGEIRTB DisplayString HLB01HTSN.0.HL1LBORNRIAPIT.HL1LBORNRIAPGC.HL1LBORNRIAPTB HLB01HTSN.0.HL1LBORNRIAPIT.HL1LBORNRIAPGC.HL1LBINRANGEAPTB DisplayString OLB01RSLTSN.0.OL1LBORNRL5HLIT.OL1LBORNRL5HLGC.OL1LBORNRL5HLTB OLB01RSLTSN.0.OL1LBORNRL5HLIT.OL1LBORNRL5HLGC.OL1LBINRANGE5HTB DisplayString OLB01RSLTSN.0.OL1LBORNRLA2LIT.OL1LBORNRLA2LGC.OL1LBORNRLA2LTB Version <1.0> Page 14 of 24
15 Alpha-Fetoprotein Anion Gap Beta 2- Microglobulin ng/ml,microgm/l,iu/ml,k IU/L,mg/dL meq/l,mmol/l Cancer Antigen U/mL,kIU/L Calcitonin Cancer Antigen 125 U/mL,kIU/L Cancer Antigen 15-3 U/mL,kIU/L Carbohydrate Antigen 19-9 Carcinoembryonic Antigen CD20 CD20/Lymphocytes % CD3 CD3/Lymphocytes % CD3+ CD4+ mg/dl,mg/l,microgm/l,mi crogm/ml,nmol/l pg/ml,ng/l,ng/ml,pmol/l U/mL,kIU/L ng/ml,microgm/l 10[3]/mm[3],/mm[3],/mic rol 10[3]/mm[3],/mm[3],/mic rol 10[3]/mm[3],/mm[3],/mic rol OLB01RSLTSN.0.OL1LBORNRLA2LIT.OL1LBORNRLA2LGC.OL1LBINRANGEA2TB DisplayString OLB01RSLTSN.0.OL1LBORNRLAFLIT.OL1LBORNRLAFLGC.OL1LBORNRLAFLTB OLB01RSLTSN.0.OL1LBORNRLAFLIT.OL1LBORNRLAFLGC.OL1LBINRANGEAFTB DisplayString OLB01RSLTSN.0.OL1LBORNRLAGLIT.OL1LBORNRLAGLGC.OL1LBORNRLAGLTB OLB01RSLTSN.0.OL1LBORNRLAGLIT.OL1LBORNRLAGLGC.OL1LBINRANGEAGTB DisplayString OLB01RSLTSN.0.OL1LBORNRLB2LIT.OL1LBORNRLB2LGC.OL1LBORNRLB2LTB OLB01RSLTSN.0.OL1LBORNRLB2LIT.OL1LBORNRLB2LGC.OL1LBINRANGEB2TB DisplayString OLB01RSLTSN.0.OL1LBORNRLCALIT.OL1LBORNRLCALGC.OL1LBORNRLCALTB OLB01RSLTSN.0.OL1LBORNRLCALIT.OL1LBORNRLCALGC.OL1LBINRANGECATB DisplayString OLB01RSLTSN.0.OL1LBORNRLCTLIT.OL1LBORNRLCTLGC.OL1LBORNRLCTLTB OLB01RSLTSN.0.OL1LBORNRLCTLIT.OL1LBORNRLCTLGC.OL1LBINRANGECTTB DisplayString OLB01RSLTSN.0.OL1LBORNRLCNLIT.OL1LBORNRLCNLGC.OL1LBORNRLCNLTB OLB01RSLTSN.0.OL1LBORNRLCNLIT.OL1LBORNRLCNLGC.OL1LBINRANGECNTB DisplayString OLB01RSLTSN.0.OL1LBORNRLCRLIT.OL1LBORNRLCRLGC.OL1LBORNRLCRLTB OLB01RSLTSN.0.OL1LBORNRLCRLIT.OL1LBORNRLCRLGC.OL1LBINRANGECRTB DisplayString OLB01RSLTSN.0.OL1LBORNRLCHLIT.OL1LBORNRLCHLGC.OL1LBORNRLCHLTB OLB01RSLTSN.0.OL1LBORNRLCHLIT.OL1LBORNRLCHLGC.OL1LBINRANGECHTB DisplayString OLB01RSLTSN.0.OL1LBORNRLCELIT.OL1LBORNRLCELGC.OL1LBORNRLCELTB OLB01RSLTSN.0.OL1LBORNRLCELIT.OL1LBORNRLCELGC.OL1LBINRANGECETB DisplayString OLB01RSLTSN.0.OL1LBORNRLCDLIT.OL1LBORNRLCDLGC.OL1LBORNRLCDLTB OLB01RSLTSN.0.OL1LBORNRLCDLIT.OL1LBORNRLCDLGC.OL1LBINRANGECDTB DisplayString OLB01RSLTSN.0.OL1LBORNRLCLLIT.OL1LBORNRLCLLGC.OL1LBORNRLCLLTB OLB01RSLTSN.0.OL1LBORNRLCLLIT.OL1LBORNRLCLLGC.OL1LBINRANGECLTB DisplayString OLB01RSLTSN.0.OL1LBORNRLC3LIT.OL1LBORNRLC3LGC.OL1LBORNRLC3LTB OLB01RSLTSN.0.OL1LBORNRLC3LIT.OL1LBORNRLC3LGC.OL1LBINRANGEC3TB DisplayString OLB01RSLTSN.0.OL1LBORNRL3LLIT.OL1LBORNRL3LLGC.OL1LBORNRL3LLTB OLB01RSLTSN.0.OL1LBORNRL3LLIT.OL1LBORNRL3LLGC.OL1LBINRANGE3LTB DisplayString OLB01RSLTSN.0.OL1LBORNRL34LIT.OL1LBORNRL34LGC.OL1LBORNRL34LTB OLB01RSLTSN.0.OL1LBORNRL34LIT.OL1LBORNRL34LGC.OL1LBINRANGE34TB Version <1.0> Page 15 of 24
16 CD3+ CD4+/Lymphocytes % CD4 CD4/Lymphocytes % CD8 CD8/Lymphocytes % Choriogonadotropin Beta Choriogonadotropin Beta Tumor Marker Circulating Plasma Cells C-Peptide C-Reactive Protein 10[3]/mm[3],/mm[3],/mic rol,10[6]/l 10[3]/mm[3],/mm[3],/mic rol miu/ml,iu/l IU/L,mIU/mL 10[3]/microL,10[9]/L,/m icrol ng/ml,nmol/l,microgm/l, pmol/l mg/dl,mg/l,nmol/l,ng/ml,microgm/ml,microgm/dl, microgm/l Creatine Kinase BB ng/ml,microgm/l Creatine Kinase BB/Total Creatine Kinase % Creatine Kinase MB ng/ml,microgm/l,ng/dl Creatine Kinase MB/Creatine Kinase % Measured Creatinine ml/min,ml/sec DisplayString OLB01RSLTSN.0.OL1LBORNRL4LLIT.OL1LBORNRL4LLGC.OL1LBORNRL4LLTB OLB01RSLTSN.0.OL1LBORNRL4LLIT.OL1LBORNRL4LLGC.OL1LBINRANGE4LTB DisplayString OLB01RSLTSN.0.OL1LBORNRLC4LIT.OL1LBORNRLC4LGC.OL1LBORNRLC4LTB OLB01RSLTSN.0.OL1LBORNRLC4LIT.OL1LBORNRLC4LGC.OL1LBINRANGEC4TB DisplayString OLB01RSLTSN.0.OL1LBORNRL4YLIT.OL1LBORNRL4YLGC.OL1LBORNRL4YLTB OLB01RSLTSN.0.OL1LBORNRL4YLIT.OL1LBORNRL4YLGC.OL1LBINRANGE4YTB DisplayString OLB01RSLTSN.0.OL1LBORNRLC8LIT.OL1LBORNRLC8LGC.OL1LBORNRLC8LTB OLB01RSLTSN.0.OL1LBORNRLC8LIT.OL1LBORNRLC8LGC.OL1LBINRANGEC8TB DisplayString OLB01RSLTSN.0.OL1LBORNRL8LLIT.OL1LBORNRL8LLGC.OL1LBORNRL8LLTB OLB01RSLTSN.0.OL1LBORNRL8LLIT.OL1LBORNRL8LLGC.OL1LBRANGE8LTB DisplayString OLB01RSLTSN.0.OL1LBORNRLCBLIT.OL1LBORNRLCBLGC.OL1LBORNRLCBLTB OLB01RSLTSN.0.OL1LBORNRLCBLIT.OL1LBORNRLCBLGC.OL1LBINRANGECBTB DisplayString OLB01RSLTSN.0.OL1LBORNRLCMLIT.OL1LBORNRLCMLGC.OL1LBORNRLCMLTB OLB01RSLTSN.0.OL1LBORNRLCMLIT.OL1LBORNRLCMLGC.OL1LBINRANGECMTB DisplayString OLB01RSLTSN.0.OL1LBORNRLCCLIT.OL1LBORNRLCCLGC.OL1LBORNRLCCLTB OLB01RSLTSN.0.OL1LBORNRLCCLIT.OL1LBORNRLCCLGC.OL1LBINRANGECCTB DisplayString OLB01RSLTSN.0.OL1LBORNRLCPLIT.OL1LBORNRLCPLGC.OL1LBORNRLCPLTB OLB01RSLTSN.0.OL1LBORNRLCPLIT.OL1LBORNRLCPLGC.OL1LBINRANGECPTB DisplayString OLB01RSLTSN.0.OL1LBORNRLCVLIT.OL1LBORNRLCVLGC.OL1LBORNRLCVLTB OLB01RSLTSN.0.OL1LBORNRLCVLIT.OL1LBORNRLCVLGC.OL1LBINRANGECVTB DisplayString OLB01RSLTSN.0.OL1LBORNRLCSLIT.OL1LBORNRLCSLGC.OL1LBORNRLCSLTB OLB01RSLTSN.0.OL1LBORNRLCSLIT.OL1LBORNRLCSLGC.OL1LBINRANGECSTB DisplayString OLB01RSLTSN.0.OL1LBORNRLTCLIT.OL1LBORNRLTCLGC.OL1LBORNRLTCLTB OLB01RSLTSN.0.OL1LBORNRLTCLIT.OL1LBORNRLTCLGC.OL1LBINRANGETCTB DisplayString OLB01RSLTSN.0.OL1LBORNRLKMLIT.OL1LBORNRLKMLGC.OL1LBORNRLKMLTB OLB01RSLTSN.0.OL1LBORNRLKMLIT.OL1LBORNRLKMLGC.OL1LBINRANGEKMTB DisplayString OLB01RSLTSN.0.OL1LBORNRLMCLIT.OL1LBORNRLMCLGC.OL1LBORNRLMCLTB OLB01RSLTSN.0.OL1LBORNRLMCLIT.OL1LBORNRLMCLGC.OL1LBINRANGEMCTB DisplayString OLB01RSLTSN.0.OL1LBORNRLMLLIT.OL1LBORNRLMLLGC.OL1LBORNRLMLLTB Version <1.0> Page 16 of 24
17 Clearance Creatinine Clearance Creatinine Clearance 24 Hour Creatinine Clearance Estimation Creatinine Clearance Estimation MDRD Dopamine Epinephrine ml/min/1.73[2],ml/sec/m [2] ml/min/1.73m[2] ml/min,ml/sec ml/min/1.73m[2] pg/ml,pmol/l,microgm/mg (creatinine),micromol/m mol(creat),microgm/gm creatinine pg/ml,pmol/l,microgm/mg (creatinine),micromol/m mol(creat),microgm/gm creatinine Epinephrine 24 Hour microgm/day,nmol/day Fibrin D-Dimer Fibrinogen Free Triiodothyronine Follitropin Globulin Hemoglobin A1C microgm/ml,mg/l,ng/ml,m icrogm/l,mg/l mg/dl,gm/l,mg/ml pg/dl,pmol/l,ng/dl,pg/m L miu/ml,iu/l gm/dl,gm/l,gm% %,mmol/mol OLB01RSLTSN.0.OL1LBORNRLMLLIT.OL1LBORNRLMLLGC.OL1LBINRANGEMLTB DisplayString OLB01RSLTSN.0.OL1LBORNRLCXLIT.OL1LBORNRLCXLGC.OL1LBORNRLCXLTB OLB01RSLTSN.0.OL1LBORNRLCXLIT.OL1LBORNRLCXLGC.OL1LBINRANGECXTB DisplayString OLB01RSLTSN.0.OL1LBORNRL24LIT.OL1LBORNRL24LGC.OL1LBORNRL24LTB OLB01RSLTSN.0.OL1LBORNRL24LIT.OL1LBORNRL24LGC.OL1LBINRANGE24TB DisplayString OLB01RSLTSN.0.OL1LBORNRLESLIT.OL1LBORNRLESLGC.OL1LBORNRLESLTB OLB01RSLTSN.0.OL1LBORNRLESLIT.OL1LBORNRLESLGC.OL1LBINRANGEESTB DisplayString OLB01RSLTSN.0.OL1LBORNREMIT.OL1LBORNREMGC.OL1LBORNREMTB OLB01RSLTSN.0.OL1LBORNREMIT.OL1LBORNREMGC.OL1LBINRANGEEMTB DisplayString OLB01RSLTSN.0.OL1LBORNRLDOLIT.OL1LBORNRLDOLGC.OL1LBORNRLDOLTB OLB01RSLTSN.0.OL1LBORNRLDOLIT.OL1LBORNRLDOLGC.OL1LBINRANGEDOTB DisplayString OLB01RSLTSN.0.OL1LBORNRLEPLIT.OL1LBORNRLEPLGC.OL1LBORNRLEPLTB OLB01RSLTSN.0.OL1LBORNRLEPLIT.OL1LBORNRLEPLGC.OL1LBINRANGEEPTB DisplayString OLB01RSLTSN.0.OL1LBORNRLEHLIT.OL1LBORNRLEHLGC.OL1LBORNRLEHLTB OLB01RSLTSN.0.OL1LBORNRLEHLIT.OL1LBORNRLEHLGC.OL1LBINRANGEEHTB DisplayString OLB01RSLTSN.0.OL1LBORNRLFDLIT.OL1LBORNRLFDLGC.OL1LBORNRLFDLTB OLB01RSLTSN.0.OL1LBORNRLFDLIT.OL1LBORNRLFDLGC.OL1LBINRANGEFDTB DisplayString OLB01RSLTSN.0.OL1LBORNRLFBLIT.OL1LBORNRLFBLGC.OL1LBORNRLFBLTB OLB01RSLTSN.0.OL1LBORNRLFBLIT.OL1LBORNRLFBLGC.OL1LBINRANGEFBTB DisplayString OLB01RSLTSN.0.OL1LBORNRLFTLIT.OL1LBORNRLFTLGC.OL1LBORNRLFTLTB OLB01RSLTSN.0.OL1LBORNRLFTLIT.OL1LBORNRLFTLGC.OL1LBINRANGEFTTB DisplayString OLB01RSLTSN.0.OL1LBORNRLFOLIT.OL1LBORNRLFOLGC.OL1LBORNRLFOLTB OLB01RSLTSN.0.OL1LBORNRLFOLIT.OL1LBORNRLFOLGC.OL1LBINRANGEFOTB DisplayString OLB01RSLTSN.0.OL1LBORNRLGLLIT.OL1LBORNRLGLLGC.OL1LBORNRLGLLTB OLB01RSLTSN.0.OL1LBORNRLGLLIT.OL1LBORNRLGLLGC.OL1LBINRANGEGLTB DisplayString OLB01RSLTSN.0.OL1LBORNRLA1LIT.OL1LBORNRLA1LGC.OL1LBORNRLA1LTB OLB01RSLTSN.0.OL1LBORNRLA1LIT.OL1LBORNRLA1LGC.OL1LBINRANGEA1TB Immunoglobulin G mg/dl,gm/l DisplayString OLB01RSLTSN.0.OL1LBORNRLIGLIT.OL1LBORNRLIGLGC.OL1LBORNRLIGLTB Version <1.0> Page 17 of 24
18 Immunoglobin M Insulin Lactic Acid Lactate Dehydrogenase-1 Isoenzyme LDH Isoenzyme 1/LDH % mg/ml,gm/l,mg/dl,mg/l microiu/ml,pmol/l mg/dl,mmol/l,meq/l IU/L,microkat/L Lipoprotein Lipase miu/ml,iu/l pg/ml,pmol/l,microgm/mg (creatinine),micromol/m mol(creat),microgm/gm Norepinephrine creatinine Norepinephrine 24 Hour Neuron-Specific Enolase Oligoclonal Bands Prostatic Acid Phosphatase Prostate Specific Antigen microgm/day,nmol/day ng/ml,microgm/l n/a Specimen Appearance n/a ng/ml,microgm/l ng/ml,microgm/l OLB01RSLTSN.0.OL1LBORNRLIGLIT.OL1LBORNRLIGLGC.OL1LBINRANGEIGTB DisplayString OLB01RSLTSN.0.OL1LBORNRLIMLIT.OL1LBORNRLIMLGC.OL1LBORNRLIMLTB OLB01RSLTSN.0.OL1LBORNRLIMLIT.OL1LBORNRLIMLGC.OL1LBINRANGEIMTB DisplayString OLB01RSLTSN.0.OL1LBORNRLINLIT.OL1LBORNRLINLGC.OL1LBORNRLINLTB OLB01RSLTSN.0.OL1LBORNRLINLIT.OL1LBORNRLINLGC.OL1LBINRANGEINTB DisplayString OLB01RSLTSN.0.OL1LBORNRLLALIT.OL1LBORNRLLALGC.OL1LBORNRLLALTB OLB01RSLTSN.0.OL1LBORNRLLALIT.OL1LBORNRLLALGC.OL1LBINRANGELATB DisplayString OLB01RSLTSN.0.OL1LBORNRL1ILIT.OL1LBORNRL1ILGC.OL1LBORNRL1ILTB OLB01RSLTSN.0.OL1LBORNRL1ILIT.OL1LBORNRL1ILGC.OL1LBINRANGE1ITB DisplayString OLB01RSLTSN.0.OL1LBORNRLI1LIT.OL1LBORNRLI1LGC.OL1LBORNRLI1LTB OLB01RSLTSN.0.OL1LBORNRLI1LIT.OL1LBORNRLI1LGC.OL1LBINRANGEI1TB DisplayString OLB01RSLTSN.0.OL1LBORNRLLLLIT.OL1LBORNRLLLLGC.OL1LBORNRLLLLTB OLB01RSLTSN.0.OL1LBORNRLLLLIT.OL1LBORNRLLLLGC.OL1LBINRANGELLTB DisplayString OLB01RSLTSN.0.OL1LBORNRLNOLIT.OL1LBORNRLNOLGC.OL1LBORNRLNOLTB OLB01RSLTSN.0.OL1LBORNRLNOLIT.OL1LBORNRLNOLGC.OL1LBINRANGENOTB DisplayString OLB01RSLTSN.0.OL1LBORNRLNHLIT.OL1LBORNRLNHLGC.OL1LBORNRLNHLTB OLB01RSLTSN.0.OL1LBORNRLNHLIT.OL1LBORNRLNHLGC.OL1LBINRANGENHTB DisplayString OLB01RSLTSN.0.OL1LBORNRLNELIT.OL1LBORNRLNELGC.OL1LBORNRLNELTB OLB01RSLTSN.0.OL1LBORNRLNELIT.OL1LBORNRLNELGC.OL1LBINRANGENETB DisplayString OLB01RSLTSN.0.OL1LBORNRLOBLIT.OL1LBORNRLOBLGC.OL1LBORNRLOBLTB OLB01RSLTSN.0.OL1LBORNRLOBLIT.OL1LBORNRLOBLGC.OL1LBINRANGEOBTB DisplayString OLB01RSLTSN.0.OL1LBORNRLPPLIT.OL1LBORNRLPPLGC.OL1LBORNRLPPLTB OLB01RSLTSN.0.OL1LBORNRLPPLIT.OL1LBORNRLPPLGC.OL1LBINRANGEPPTB DisplayString OLB01RSLTSN.0.OL1LBORNRLPALIT.OL1LBORNRLPALGC.OL1LBORNRLPALTB OLB01RSLTSN.0.OL1LBORNRLPALIT.OL1LBORNRLPALGC.OL1LBINRANGEPATB DisplayString OLB01RSLTSN.0.OL1LBORNRLSALIT.OL1LBORNRLSALGC.OL1LBORNRLSALTB OLB01RSLTSN.0.OL1LBORNRLSALIT.OL1LBORNRLSALGC.OL1LBINRANGESATB Thyroglobulin ng/ml,microgm/l DisplayString OLB01RSLTSN.0.OL1LBORNRLTHLIT.OL1LBORNRLTHLGC.OL1LBORNRLTHLTB Version <1.0> Page 18 of 24
19 Thyroglobulin Antibody Thyroxine Total Thyrotropin Vanillylmandelic Acid <!--ULB01AFM--> Hemoglobin ph Specific Gravity Urinalysis <!--ULB01FM--> Leukocyte Esterase Nitrite Protein Glucose Ketones IU/mL,kIU/L microgm/dl,nmol/l microiu/ml,miu/l,iu/ml, miu/ml,microiu/l microgm/mg(creatinine), mmol/mol(creatinine),mg /gm(creatinine) Character Result,mg/dL,mg/L,10[6] /L,/microL,/mL n/a n/a n/a Character Result,/microL,10[6]/L Character Result,mg/dL,micromol/L Character Result,mg/dL,mg/dL,mg/L,gm/L,gm/dL,mg% Character Result,mg/dL,mmol/L,gm/ dl,mg/l,gm/l Character Result,mg/dL,mmol/L OLB01RSLTSN.0.OL1LBORNRLTHLIT.OL1LBORNRLTHLGC.OL1LBINRANGETHTB DisplayString OLB01RSLTSN.0.OL1LBORNRLTALIT.OL1LBORNRLTALGC.OL1LBORNRLTALTB OLB01RSLTSN.0.OL1LBORNRLTALIT.OL1LBORNRLTALGC.OL1LBINRANGETATB DisplayString OLB01RSLTSN.0.OL1LBORNRLTTLIT.OL1LBORNRLTTLGC.OL1LBORNRLTTLTB OLB01RSLTSN.0.OL1LBORNRLTTLIT.OL1LBORNRLTTLGC.OL1LBINRANGETTTB DisplayString OLB01RSLTSN.0.OL1LBORNRLTRLIT.OL1LBORNRLTRLGC.OL1LBORNRLTRLTB OLB01RSLTSN.0.OL1LBORNRLTRLIT.OL1LBORNRLTRLGC.OL1LBINRANGETRTB DisplayString OLB01RSLTSN.0.OL1LBORNRLVALIT.OL1LBORNRLVALGC.OL1LBORNRLVALTB OLB01RSLTSN.0.OL1LBORNRLVALIT.OL1LBORNRLVALGC.OL1LBINRANGEVATB DisplayString ULB01ACRSN.0.UL1ALBORNRHGUIT.UL1ALBORNRHGUGC.UL1ALBORNRHGUTB ULB01ACRSN.0.UL1ALBORNRHGUIT.UL1ALBORNRHGUGC.UL1ALBINRANGEHGTB DisplayString ULB01ACRSN.0.UL1ALBORNRPHUIT.UL1ALBORNRPHUGC.UL1ALBORNRPHUTB ULB01ACRSN.0.UL1ALBORNRPHUIT.UL1ALBORNRPHUGC.UL1ALBINRANGEPHTB DisplayString ULB01ACRSN.0.UL1ALBORNRSGUIT.UL1ALBORNRSGUGC.UL1ALBORNRSGUTB ULB01ACRSN.0.UL1ALBORNRSGUIT.UL1ALBORNRSGUGC.UL1ALBINRANGESGTB DisplayString ULB01ACRSN.0.UL1ALBORNRUUIT.UL1ALBORNRUUGC.ULA1LBORNRUUTB ULB01ACRSN.0.UL1ALBORNRUUIT.UL1ALBORNRUUGC.ULA1LBINRANGEUTB DisplayString ULB01CRSN.0.UL1LBORNRERIT.UL1LBORNRERGC.UL1LBORNRERTB ULB01CRSN.0.UL1LBORNRERIT.UL1LBORNRERGC.UL1LBINRANGELETB DisplayString ULB01CRSN.0.UL1LBORNRLNIT.UL1LBORNRLNGC.UL1LBORNRLNTB ULB01CRSN.0.UL1LBORNRLNIT.UL1LBORNRLNGC.UL1LBINRANGENTB DisplayString ULB01CRSN.0.UL1LBORNRPRUIT.UL1LBORNRPRUGC.UL1LBORNRPRUTB ULB01CRSN.0.UL1LBORNRPRUIT.UL1LBORNRPRUGC.UL1LBINRANGEPRTB DisplayString ULB01CRSN.0.UL1LBORNRGLUIT.UL1LBORNRGLUGC.UL1LBORNRGLUTB ULB01CRSN.0.UL1LBORNRGLUIT.UL1LBORNRGLUGC.UL1LBINRANGEGLTB DisplayString ULB01CRSN.0.UL1LBORNRKTUIT.UL1LBORNRKTUGC.UL1LBORNRKTUTB ULB01CRSN.0.UL1LBORNRKTUIT.UL1LBORNRKTUGC.UL1LBINRANGEKTTB Version <1.0> Page 19 of 24
20 Character Result,mg/dL,u/dL,mmol/ Urobilinogen L,micromol/L Bilirubin Blood Character Result,mg/dL,micromol/L Character Result,/microL,/mL,10[6 ]/L DisplayString ULB01CRSN.0.UL1LBORNRUBUIT.UL1LBORNRUBUGC.UL1LBORNRUBUTB ULB01CRSN.0.UL1LBORNRUBUIT.UL1LBORNRUBUGC.UL1LBINRANGEUBTB DisplayString ULB01CRSN.0.UL1LBORNRBUIT.UL1LBORNRBUGC.UL1LBORNRBUTB ULB01CRSN.0.UL1LBORNRBUIT.UL1LBORNRBUGC.UL1LBINRANGEBTB DisplayString ULB01CRSN.0.UL1LBORNRBLUIT.UL1LBORNRBLUGC.UL1LBORNRBLUTB ULB01CRSN.0.UL1LBORNRBLUIT.UL1LBORNRBLUGC.UL1LBINRANGEBLTB RID 5 IIE-LNMT Configuration This section should be used to configure the content and distribution list for s generated by IIE-LNMT. It is recommended to use address distribution lists instead of individual addresses for easier maintenance. CATEGORY PARAMETERS Success From: <trialname>@webcrf.net To: <Sponsor list> Subject: IIE-LNMT Data Import/Export Success Body: Include tokens: Trial Name Vendor Name File Name Patient Number Patient Initials Site Mnemonic (Patient Number, Initials and Site Mnemonic are available Version <1.0> Page 20 of 24
21 Oracle Recommendations for import process flow and MedML format.) The IIE-LNMT solution will send this category of when data is imported or exported successfully. Oracle recommendations are listed above. Oracle Customer Support should not be listed in the To: section for this category of . Please change this based on the requirements. Configuration Error From To Subject Body Oracle Recommendations <Oracle Customer Support>, <Oracle Technical Consulting> IIE-LNMT Configuration Error Include tokens: Trial Name Vendor Name File Name Patient Number Patient Initials Site Mnemonic (Patient Number, Initials and Site Mnemonic are available for import process flow and MedML format.) The IIE-LNMT solution will send this category of when an import or export error is encountered that is the result of a configuration problem. Oracle recommendations are listed above. This should NOT be sent to Sponsor or Vendor. Please change this based on the Version <1.0> Page 21 of 24
22 Application Error From To Subject requirements. <Sponsor list>, <Vendor list>, <Oracle Customer Support>, <Oracle Technical Consulting> IIE-LNMT Application Error Import Error Body Oracle Recommenda tions From Include tokens: Trial Name Vendor Name File Name Patient Number Patient Initials Site Mnemonic (Patient Number, Initials and Site Mnemonic are available for import process flow and MedML format.) The IIE-LNMT solution will send this category of when an import or export error is encountered during the pre-processing steps. Oracle recommendations are listed above. This should be sent to Sponsor or Vendor. Please change this based on the requirements. Version <1.0> Page 22 of 24
23 To Subject <Sponsor list>, <Vendor list>, <Oracle Customer Support>, <Oracle Technical Consulting> IIE-LNMT Data Import Error Body Oracle Recommendations Include tokens: Trial Name Vendor Name File Name Patient Number Patient Initials Site Mnemonic (Patient Number, Initials and Site Mnemonic are available for import process flow and MedML format.) The IIE-LNMT solution will send this category of when an error is encountered during the data import process. Oracle recommendations are listed above. This should be sent to Sponsor and Vendor. Please change this based on the requirements. Export Error From To <Sponsor list>, <Vendor list>, <Oracle Customer Support>, <Oracle Technical Consulting> Subject IIE-LNMT Data Export Error Body Include tokens: Trial Name Vendor Name Version <1.0> Page 23 of 24
24 Enable Sending s [Required] SMTP Server [Required] Oracle Recommendations File Name Patient Number Patient Initials Site Mnemonic (Patient Number, Initials and Site Mnemonic are available for import process flow and MedML format.) The IIE-LNMT solution will send this category of when an error is encountered during the data export process. Oracle recommendations are listed above. This should be sent to Sponsor and Vendor. Please change this based on the requirements. Default: Enabled Change to override default. Default: Oracle SMTP Server Change to override default. Version <1.0> Page 24 of 24
How to Use the Lab and Pathology Portlet
The Lab and Pathology Results portlet displays consolidated diagnostic laboratory tests from Ontario Laboratories Information System (OLIS) for patients with an Ontario Health Number. 1. In the Patient
More informationCERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION In terms of section 22 (2) (b) of the Accreditation for Conformity Assessment, Calibration and Good Laboratory Practice Act, 2006 (Act 19 of 2006), read with sections 23 (1),
More informationRIQAS RANDOX INTERNATIONAL QUALITY ASSESSMENT SCHEME ENROLMENT DOCUMENT GENERAL CLINICAL CHEMISTRY PROGRAMME RQ9112/9113
RIQAS RANDOX INTERNATIONAL QUALITY ASSESSMENT SCHEME ENROLMENT DOCUMENT GENERAL CLINICAL CHEMISTRY PROGRAMME RQ9112/9113 This document must be completed and returned to RIQAS RIQAS GENERAL CLINICAL CHEMISTRY
More informationPARTICIPANT STATISTICS Chemistry Q Chemistry i-stat. Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5
PARTICIPANT STATISTICS Chemistry Q 20 Chemistry i-stat Name Bicarbonate (Total CO2) - istat 25.0-37.0 P 30.9..0-9.0 C 5.4 0.7 8.0-26.0 P 22. 0.4 24.0-35.0 P 29.4.0 39.0-58.0 P 48.3.7 9 24.0-36.0 P 30..6.0-9.0
More informationTRACEABILITY and UNCERTAINTY 7
cobas c 01 / c 02 / c 11 / c 701 / c 702 - C.f.a.s. Cat. No. 10 79 0 190 ACP2 Acid phosphatase total 1-naphthyl phosphate Gen. 2 ACP2 Acid phosphatase, non-prostatic 1-naphthyl phosphate (Inhib.:tartrate)
More informationMore to Life. Where research becomes the basis of discovering newer ways of alleviating human suffering and empowering an individual with good health.
More to Life Where research becomes the basis of discovering newer ways of alleviating human suffering and empowering an individual with good health. Meril Diagnostics Emerging from a lineage of successful
More informationLooking for SDTM Migration Specialist
Paper CD13 Looking for SDTM Migration Specialist Angelo Tinazzi, Cytel Inc., Geneva, Switzerland ABSTRACT Despite CDISC became a widely accepted standard for electronic data submission with US-FDA soon
More informationReagent and Supplies Order Form for use on Olympus AU
General Chemistries - Reagents ALB (Albumin) AU-224 3 x 250 tests ALP (Alkaline Phosphatase) AU-206 3 x 250 tests ALT (Alanine Transaminase) AU-240 3 x 250 tests AMY (Amylase) AU-227 3 x 100 tests APO
More informationResveratrol mitigates lipopolysaccharide-mediated acute. inflammation in rats by inhibiting the TLR4/NF-κBp65/MAPKs.
Resveratrol mitigates lipopolysaccharide-mediated acute inflammation in rats by inhibiting the TLR4/NF-κBp65/MAPKs signaling cascade Guangxi Wang a,1, Zhiqiang Hu b,1, Qiuting Fu a,1, Xu Song a,1, Qiankun
More informationAdult Inpatient Rounding Report mpage
Adult Inpatient Rounding Report mpage The Adult Inpatient Rounding Report MPage is found under Multi-Patient List MPage icon on a toolbar at the top of the screen. It displays patients on a list you have
More informationCORPORATE PRESENTATION
CORPORATE PRESENTATION Fourth Quarter Fiscal Year 2016 NASDAQ: ABAX DISCLAIMER This corporate presentation includes statements that constitute forward-looking statements within the meaning of the Private
More informationQS RESULTS INTRODUCTION AND REPORTS
EQAS.GR URBINO UNIVERSITY BIO GROUP MEDICAL SYSTEM Index: QS PROGRAMS GENERAL CONDITIONS... 2 RESULTS INTRODUCTION... 4 CLINICAL CHEMISTRY SCREEN:... 10 HEMATOLOGY SCREEN:... 11 IMMUNOLOGY SCREEN:... 12
More informationHaematology/Blood Transfusion. Uncertainty of Measurement values. Haemoglobin g/l / g/l
Haematology/Blood Transfusion Uncertainty of Measurement values Full Blood Count WBC
More informationManual 13 Data Management
Manual 13 Data Management January 23, 2008 - Version 1.0 Study website - http://www.cscc.unc.edu/hchs/ Data Management TABLE OF CONTENTS 1. HCHS / SOL FIELD CENTER DATA MANAGEMENT 1 1.1. Web-Based Data
More informationUrine Preservatives Collection and Transportation for 24-Hour Urine Specimens
Preservatives Collection and Transportation for 24-Hour Specimens The Department of Laboratory Medicine and Pathology at Mayo Clinic initiated a study to determine stability of analytes under different
More informationUrine Preservatives Collection and Transportation for 24-Hour Urine Specimens
Preservatives Collection and Transportation for 24-Hour Specimens The Department of Laboratory Medicine and Pathology at Mayo Clinic initiated a study to determine stability of analytes under different
More informationNEMSIS Data Dictionary
NEMSIS Data Dictionary NHTSA v3.4.0 Build 150302 Med Device Data Standard Version Date: March 2, 2015 Funded by National Highway Traffic Safety Administration (NHTSA) ffice of Emergency Medical Services
More informationThe connection used is a standard Serial Cable with female connectors on both ends. Serial Port Setup should be as follows: Baud = 9600
Heska CBC-Diff Make sure they have a CBC-Diff or SpotChem EZ machine, the earlier model ABC Hematology does not work with Intravet. If the clients wish to use both machines they need to have 2 serial ports
More informationUrine Preservatives Collection and Transportation for 24-Hour Urine Specimens
The Department of Laboratory Medicine and Pathology at Mayo Clinic initiated a study to determine stability of analytes under different preservative conditions. This reference chart, built from that study,
More informationUrine Preservatives Collection and Transportation for 24-Hour Urine Specimens
Preservatives Collection and Transportation for 24-Hour Specimens The Department of Laboratory Medicine and Pathology at Mayo Clinic initiated a study to determine stability of analytes under different
More informationLab ID 406. Your Parameters. Institution: Analyte. WBC Siemens Advia 120 Siemens 10 9 /L. RBC Siemens Advia 120 Siemens /L
Your Parameters Institution: Analyzer Reagent Cat N Reagent Manufacturer Method Group Calibrator Cat n Calibrator Cal Lot # Unit WBC Siemens Advia 12 Siemens 1 9 /L RBC Siemens Advia 12 Siemens 1 12 /L
More informationABC clinical diagnostic solutions
ABC clinical diagnostic solutions RX imola Compact fully automated random access benchtop clinical analyser 400 photometric tests, 240 ISE tests per hour Easy-to-use modern Windows based software Unrivalled
More informationREGISTRY OF SEVERE CUTANEOUS ADVERSE REACTIONS TO DRUGS AND COLLECTION OF BIOLOGICAL SAMPLES. R e g i S C A R PATIENT'S DATA. Age country of birth
REGISTRY OF SEVERE CUTANEOUS ADVERSE REACTIONS TO DRUGS AND COLLECTION OF BIOLOGICAL SAMPLES R e g i S C A R PATIENT'S DATA Initials of the patient date of birth Age country of birth Gender male female
More informationDistributed Research Networks: Lessons from the Field
Distributed Research Networks: Lessons from the Field The Learning System Summit Sponsored by the Joseph H. Kanter Family Founda8on The Na(onal Press Club Washington, DC May 17-18, 2012 Jeffrey Brown,
More informationPART III APPLICATIONS
S. Vieira PART III APPLICATIONS Fuzz IEEE 2013, Hyderabad India 1 Applications Finance Value at Risk estimation based on a PFS model for density forecast of a continuous response variable conditional on
More information3. SOURCES OF DATA. 3.1 Data Management Activities
3. SOURCES OF DATA Data for the central database will come from a variety of sources and include the following. Basic clinical information and data obtained from outcome assessments performed at each site,
More informationINVITATION TO BID. (This is not an order.)
Page 1 of 9 SCHEDULE OF EVENTS Event Description 1 / 1 Roche Diagnostics POC Chemstrip Urine Test Strips 2.00000 / Event Date #: BC417109; For Urinalysis; Product Type: Chemstrip 9; Detectable Analytes:
More informationGeotech Services, X-18, MIDC, Hingna, Nagpur, Maharashtra. Discipline Chemical Testing Issue Date
Last Amended on 11.01.2014 Page 1 of 6 I. WATER 1. WATER (For Construction Purpose Only) ph Value IS 3025 (Part 11) : 1983 (Clause 2.0) Suspended Matter IS 3025 (Part 17) : 1984 Organic matter IS 3025
More informationHST 952 Fall Project
Project The project builds upon the database you designed in Homeworks 8 and 9. It also will utilize many of the skills you have developed in previous segments of this course. You will develop a part of
More information0.1-4 mg/dl or μmol/l or mmol/l 152 Upper limit of normal for your institution creatinine
s Recipient Baseline Data (Form 2000) 141 AST (SGOT) 0-200 U/L or 0-3.2 μkat/l 144 Total serum bilirubin 0.2-15 mg/dl or 3.5-263 μmol/l 146 Upper limit of normal for your institution - bilirubin 0.2-2.5
More informationBeckman Coulter Professional Development 2014 Beckman Coulter, Inc. 1of 50
THE BECKMAN COULTER logo, COULTER, DxH, TruColor, and UniCel are trademarks of Beckman Coulter, Inc; COULTER and UniCel are registered in the USPTO. 1of 50 Objectives Flags Codes Messages CBC Parameters
More information2010 WEST MEDICA VETERINARY EQUIPMENT CATALOGUE
2010 WEST MEDICA VETERINARY EQUIPMENT CATALOGUE COMPANY PROFILE Dear Colleagues! West Medica company specializes in manufacturing and distribution of veterinary diagnostic equipment. The company was established
More informationAMERICAN ASSOCIATION OF BIOANALYSTS 205 West Levee St. Brownsville, TX (281) (800) Fax (713)
Amylase - Initial Grouping by Method Beckman AMY 1 213.5-396.6 P 305.07 10.1 92.6-172.1 P 132.36 7.9 14 Siemens Dimension 2 129.4-240.2 P 184.79 3.4 51.0-94.6 P 72.80 4.3 20 Extremely low recovery meth
More informationCellaVision. Ola Andersson Peter Wilson. Siemens Belgium
CellaVision Ola Andersson Peter Wilson Siemens Belgium CellaVision in short Headquarters in Lund, Sweden Around 80 employees globally Market support offices in the Nordic countries, the US, Canada, Japan,
More informationTest requesting in EMIS LV using Sunquest ICE
GP ICE User Guide 1 Placing a request... 3 1.1 Navigating around the test request screen...4 1.1.1 Panels and pages... 4 1.1.2 Selecting a test... 4 1.1.3 Excluded tests... 4 1.1.4 Included tests... 5
More informationTesting Procedures for i-stat Chemistry Cartridges
Testing Procedures for i-stat Chemistry Cartridges These testing procedures are for use with the following CLIA-waived i-stat cartridges: CHEM8+, 6+, EC4+, E3+, Crea, and G. These cartridges include various
More informationHematology Program (BC90A/BC90B/BC90C/BC90D/CS90A/CS90B/CS90C/CS90D) Cycle 11: March 2016 February Sample No: 1 Sample Date: 14 Apr 16
Exceptions (BC90A/BC90B/BC90C/BC90D/CS90A/CS90B/CS90C/CS90D) : March 206 February 207 None at this time. Legend: No Warnings Missing Result Late Results < < > * Amended Result (per participant s request)
More information2010 WEST MEDICA VETERINARY EQUIPMENT CATALOGUE
2010 WEST MEDICA VETERINARY EQUIPMENT CATALOGUE COMPANY PROFILE Dear Colleagues! West Medica company specializes in manufacturing and distribution of veterinary diagnostic equipment. The company was established
More informationAutomatic analyzer Reagent system. Random access STAT (immediate access and execution) Barcode reader. Built-in for reagents, optional for samples ISE
Specifications & more HumaStar 150SR > > System Specifications > > Reagents > > Consumables > > Accessories System Overview Cat.No. 16920 Analyzer type Automatic analyzer Reagent system Closed System Throughput
More informationADULT MASSIVE BLOOD TRANSFUSION PROTOCOL
Manual: Administrative Policies and Procedures Manual Policy Number: 01.3.35 Pages: 1 of 5 Initial Date: 8/15 Review Dates: Revised Dates: Purpose: ADULT MASSIVE BLOOD TRANSFUSION PROTOCOL To provide information
More informationPRODUCT CATALOG Solutions for Clinical Diagnostics
PRODUCT CATALOG Solutions for Clinical Diagnostics TOSOH BIOSCIENCE CONTENTS Placing Your Order 2 Information Needed for Order Placement 2 Standing Orders 2 Pricing and Quotations 2 Payment 2 Shipping
More informationModeling Decision Support Rule Interactions in a Clinical Setting
Modeling Decision Support Rule Interactions in a Clinical Setting Margarita Sordo, Beatriz H. Rocha, Alfredo A. Morales, Saverio M. Maviglia, Elisa Dell Oglio, Amanda Fairbanks, Teal Aroy, David Dubois,
More informationKit Contents FH9-06 FH9-10 BCP-11 BCP-20 CD-ROM. Important: Before You Begin. New for this Mailing
Comprehensive Hematology Survey Automated Differential FH9 FH9P 2FH9 FH9-B 2014 Kit Instructions CAP 2014 Table of Contents Kit Contents Kit Contents... 1 Important: Before You Begin... 1 Detailed Testing
More informationTENDER NOTICE NO. DMHS/LAB/2009/398 DT. 22/05/2009 Laboratory Items
TENDER NOTICE NO. DMHS/LAB/2009/398 DT. 22/05/2009 Laboratory Items Sr. Approximate Rate per LABORATORIES KITS 1 ASO Test kit (Latex) Slide method 500 test 10 test Beacon/Tranasia 2 Blood Glucose Auto
More informationProcessing haematological data on a network environment
Malaysian J Pathol 1995; 17(2): 77-81 Processing haematological data on a network environment ZAINAL AG DMLT* and SK CHEONG FRCP,FRCPA Department of Pathology and Medicine*, Faculty of Medicine, Universiti
More informationTest requesting in EMIS Web using Sunquest ICE
GP ICE User Guide Test requesting in EMIS Web using Sunquest ICE 1 Placing a request... 3 1.1 Navigating around the test request screen...4 1.1.1 Panels and pages... 4 1.1.2 Selecting a test... 4 1.1.3
More informationAdditionally, all handheld analyzers currently in stock should be updated immediately with this software prior to shipping to customers.
i-stat DISTRIBUTOR BULLETIN i-stat Software Release Summary October 2011 i-stat Portable Clinical Analyzer: JAMS064 CLEW A23 or C23 (for Japan only) i-stat 1 Analyzer: JAMS131, CLEW A23 i-stat 300F Analyzer
More informationEvolution of Massive Transfusion Strategies
Evolution of Massive Transfusion Strategies Kerry Gunn Department of Anaesthesia and Perioperative Medicine Auckland City Hospital Conflict of Interest Honorarium for Novo Nordisk to Chair Meetings Summary
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Case Report Forms SOP Number: 5 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review date: August 2015
More informationLocal Lab Normal Range Management Tool (LNMT) Site Job Aid for Late Stage Development
Supporting Document 600-GDMS040-005 Local Lab Normal Range Management Tool (LNMT) Site Job Aid for Late Stage Development Version 1.0 Revision History Version Effective Date Revised by Changes 1 01-Jan-2012
More informationID Admin Section 5 Analyzer Operation...17 Entering Canister Code...19 Normal Operation, no Barcode reader...20
Table of Contents Section 1 Introduction... 1 Intended Use... 1 Section 2 Analyzer Components... 2 Analyzer Component Illustrations... 2 Section 3 Initial Startup... 3 Section 4 Analyzer Setup... 5 Test
More informationQuick Reference Guide for the i-stat 1 Handheld and i-stat Chemistry Cartridges
Quick Reference Guide for the i-stat 1 Handheld and i-stat Chemistry Cartridges For use with a CLIA Certificate of Waiver G 6+ EC4+ Crea CHEM8+ E3+ Quick Reference Guide for the i-stat 1 Handheld and i-stat
More informationPAPER ON MULTIPLE TIME SERIES CLINICAL DATA PROCESSING FOR DIFFERENT TYPES OF STATICALLY MEASUREMENT
PAPER ON MULTIPLE TIME SERIES CLINICAL DATA PROCESSING FOR DIFFERENT TYPES OF STATICALLY MEASUREMENT Snehal Bagde 1 Professor. Ms. Bhagyashree Madan 2 Abstract: - In this paper, we present another bit
More informationClinical Database acceptance: what statistical review checks are necessary to validate a database?
Paper DH02 Clinical Database acceptance: what statistical review checks are necessary to validate a database? Genevieve Jehl, Quintiles, Strasbourg, France ABSTRACT (HEADER 1) Statistical checks for database
More informationOFFICE OF THE CHF DISTRICT MEDICAL & PUBLIC HEALTH OFFICER, MALKANGIRI TENDER CALL NOTICE
OFFICE OF THE CHF DISTRICT MEDICAL & PUBLIC HEALTH OFFICER, MALKANGIRI No.9041/XIV-P(D & C) 09/2017, dated, Malkangiri the 15 th November 2017 TENDER CALL NOTICE Sealed Tenders are invited from the Registered
More informationTotal WBC count and differential WBC count HemoCue WBC DIFF system
TLM_PRO_029 and Version No. 001 Page 1 of 6 Department: Clinical Sciences Unit: Tropical Laboratory Medicine Total WBC count and differential WBC count HemoCue WBC DIFF system Project/study: Not applicable
More informationBoule Medical AB CA620-CellGuard Page Usermanual V3.7
1 File : 620-CellGuard -30-370 Software version V3.7x Article number of this manual : 1504038 Table of contents 1 Identification of hazards & interpretation of results...5 1.1 Interpretation of results...6
More informationTable of Contents Section 1 Introduction...1 Intended Use... 1 Section 2 Analyzer Components...2 Analyzer Component Illustrations...
Table of Contents Section 1 Introduction...1 Intended Use... 1 Section 2 Analyzer Components...2 Analyzer Component Illustrations... 2 Section 3 Initial Startup...3 Section 4 Analyzer Setup...5 Test Settings...
More informationA heuristic approach in hepatic cancer diagnosis using a probabilistic neural network-based model
A heuristic approach in hepatic cancer diagnosis using a probabilistic neural network-based model Marina Gorunescu 1, Florin Gorunescu 2, Marius Ene 2, and Elia El-Darzi 3 1 Faculty of Mathematics and
More informationQuickScan Touch Visible Scanning Densitometer Operator's Manual Catalog Numbers 1690, 1691, and 1692
QuickScan Touch Visible Scanning Densitometer Operator's Manual Catalog Numbers 1690, 1691, and 1692 QuickScan Touch Visible Scanning Densitometer Operator s Manual WARNING! DO NOT ATTEMPT TO MOVE, INSTALL,
More informationAdding to platelet safety & life: Experience with Platelet Additive Solution(PAS)
Adding to platelet safety & life: Experience with Platelet Additive Solution(PAS) Dr. Ankit Mathur Consultant Transfusion Medicine & Transplant Immunology 1 Single Donor Platelet Transfusion Single Donor
More informationUser Guide. Quality Check Messages and Codes (continued) (01) Message Cause Action
Quality Check Messages and Codes (continued) Message Cause Action i-stat Analyzer Error, Use Electronic Simulator Analyzer Error, See Manual No display Cartridge Locked does not disappear after test cycle
More informationBC Auto Hematology Analyzer. Pleasant Experience in Hematology Testing
BC-3600 Auto Hematology Analyzer Pleasant Experience in Hematology Testing BC-3600 Auto Hematology Analyzer Labs today are facing a multitude of challenges including limited laboratory budgets, increasing
More informationRAA040AEN OUTPUT FORMATS PENTRA 80 / XL80
RAA040AEN OUTPUT FORMATS PENTRA 80 / XL80 Table of Contents -> Introduction page 3 -> Connection, page 4 -> ASTM Format page 6 -> ABX Format page 22 RAA040AEN HORIBA ABX PROPERTY 2 Introduction ASTM Format
More informationNext Generation Hematology Analyzer. BeneSphera H33s. Minimum Size, Maximum Capability
Next Generation Hematology Analyzer BeneSphera H33s Minimum Size, Maximum Capability H33s BeneSphera BeneSphera H33s Next Generation Hematology Analyzer What a 3-part should be Avantor s new line of hematology
More informationHematology Analyzer. User s Manual. Revision 2.17
Abacus junior 5 Hematology Analyzer User s Manual Revision 2.17 TABLE OF CONTENTS 1 INTRODUCTION... 1-1 1.1 Intended Use... 1-1 1.2 General Description... 1-1 1.2.1 The Instrument... 1-1 1.2.2 Patient
More informationINSCRIBE SHORTCUT PROGRAM USING ASR-ENHANCED SHORTCUTS WITH STRUCTURED
INSCRIBE SHORTCUT PROGRAM USING ASR-ENHANCED SHORTCUTS WITH STRUCTURED TABLE OF CONTENTS Week 11 CTRL + ALT + G, SHIFT + CTRL + G, F3, F4, SHIFT + AL T+, shift + alt +... 2 CTRL + ALT + G (Insert dictation
More informationTable of Contents Section 1. Introduction...2 Section 2. Analyzer Components...3 Analyzer Flow Diagram... 3 Analyzer Component Illustrations...
Table of Contents Section 1. Introduction...2 Section 2. Analyzer Components...3 Analyzer Flow Diagram... 3 Analyzer Component Illustrations... 4 Section 3. Analyzer Settings...5 Screen Navigation... 5
More informationThis document serves as a guide only and does not supersede clinical judgment.
CCAT istat Use Clinical Practice Guideline Original Release Date: Mar 2013 Most Recent Review/Revision: 19 Mar 2013 Authors and Peer Reviewers: Capt John-Michael Fowler, Peer Reviewers: SSgt Tyler Britton,
More informationHematology & Clinical Chemistry
Hematology & Clinical Chemistry Reagents, consumables and customer support Catalogue 2012 Hematology & Clinical Chemistry Reagents, consumables and customer support Catalogue 2012 Dear customer and partner,
More informationContents. Preface Safety Instruction Specifications Measuring Principles Parameter Flags... 33
User s Manual Medonic CA620 + MPA + AD Medonic CA620 + MPA Medonic CA620 Medonic CA530 + MPA + AD Medonic CA530 + MPA Medonic CA530 Medonic CA620-CellGuard + MPA + AD Medonic CA620-CellGuard + MPA Contents
More informationINTRODUCTION SPECIFICATIONS
Documentation for the MIMIC-III Dataset Generation Library (MDGL) Ty Vaughan 2018 MS/CS PILOT EECS Department, Univ. of Tennessee INTRODUCTION This report contains the documentation for the Mimic-III Dataset
More informationQuickScan Touch plus
Visible Scanning Densitometer Operator's Manual Catalog Numbers 1690, 1691, and 1692 Visible Scanning Densitometer Operator s Manual WARNING! DO NOT ATTEMPT TO MOVE, INSTALL, OR OPERATE THIS INSTRUMENT
More informationP A T I E N T C E N T E R E D M E D I C A L H O M E ( P C M H ) A T T E S T A T I O N O F F A C I L I T Y C O M P L I A N C E
P A T I E N T C E N T E R E D M E D I C A L H O M E ( P C M H ) A T T E S T A T I O N O F F A C I L I T Y C O M P L I A N C E State of Wyoming, Department of Health, Division of Healthcare Financing 2015
More informationTable of Contents. I. Logging into Camden HIE... 3 II. Basic Home View... 4
Clinical User Guide Revised April, 2018 Table of Contents HIE Basics I. Logging into Camden HIE..... 3 II. Basic Home View... 4 Applications Dashboard III. My Patients List... 5-7 IV. Inside a patient
More informationAbacus plus. Hematology Analyzer. User s Manual release
Abacus plus Hematology Analyzer User s Manual 1.00 release Revision history: Revision Section Modification By At 0.03 All Parallel printer version Support team 19.06.2006. 1.00 1, 7 USB printer version
More informationMISSING DATA REPORT Survey Data
MISSING DATA REPORT Survey Data 2012-2016 Abstract The rates of non response for ANZDATA survey items over the last 5 years anzdata@anzdata.org.au www.anzdata.org.au The tables below show the rates of
More informationUM-AJV Abacus Junior Vet User s Manual
UM-AJV-01-276 Abacus Junior Vet User s Manual REVISION-HISTORY Date Name Signature Issued 06/10/2009 Ildiko Losonczi Checked and approved 06/10/2009 Csaba Magyar Abacus Junior Vet Hematology Analyzer User
More informationInForm Functionality Reference Manual for Sites. Version 1.0
InForm Functionality Reference Manual for Sites Version 1.0 1-Mar-2012 2012 by Merck & Co., Inc., Whitehouse Station, New Jersey, USA All Rights Reserved No part of this book may be reproduced in any form
More informationDate Name Signature Issued 06-MAY-2011 Csaba Magyar Checked and approved 17-MAY-2011 Gábor Farkas
Revision history OM-ACS30-01-1110 Rev. Date Edited by Sections affected Approved by 1.0 2009-06-02 Arpad Gyetvai Initial revision Csaba Magyar 1.1 2010-03-25 Gabor Farkas First review, new GUI screenshots
More informationMINI-SENTINEL COORDINATING CENTER DATA CORE
MINI-SENTINEL COORDINATING CENTER DATA CORE YEAR TWO COMMON DATA MODEL (CDM) REPORT REPORT OF DATA CORE ACTIVITIES, OCTOBER 2010 - SEPTEMBER 2011 Prepared by: Mini-Sentinel Data Core and Data Partners
More informationOM-A Revision history Rev. Date Edited by Sections affected Approved by
OM-A380-01-115 Revision history Rev. Date Edited by Sections affected Approved by 1.0 2010.05.14 Gabor Farkas Initial revision 1.1 2010.07.27. Gabor Farkas Reagent Lock System added, Profile settings added,
More informationVeterinary User Guide
Veterinary User Guide Epocal Inc. Emergo Europe 2060 Walkley Road Molenstraat 15, 2513 BH Ottawa, Ontario, The Hague, Netherlands Canada K1G 3P5 Tel: +31.70.345.8570 Tel: (613) 738-6192 Fax: +31.70.346.7299
More informationCreating Efficient SQL The De-normalize Transpose Paul D Sherman, San Jose, CA
Paper PO42 Creating Efficient SQL The De-normalize Transpose Paul D Sherman, San Jose, CA ABSTRACT Normalization and warehousing are battle cries of two waring factions. Although vertical or row-wise designs
More information05/12/2011 Revision: 04/19/2011 Revision:
Collaborative Stage Version 2: 020000/020001/020100/020200 to Collaborative Stage Version 2: 020300/020301/020302 Revised Conversion Specifications/Release Notes 2/15/2011 Revised Conversion Specifications/Release
More informationDiscrepancy Management
Discrepancy Management While working in OC RDC, you will encounter discrepancies with various assigned statuses. The description of each type of status is listed below. Unreviewed This is the Unreviewed
More informationClinical Data Acquisition Standards Harmonization (CDASH) User Guide
Clinical Data Acquisition Standards Harmonization (CDASH) Prepared by: CDISC CDASH Project Team CDASH_UG-1.0 19 April 2010 CDASH V1.0 Table of Contents Section Page 1.0 Introduction... 1 1.1 Purpose...
More information1. Study Registration. 2. Confirm Registration
USER MANUAL 1. Study Registration Diabetic patients are more susceptible to experiencing cardiovascular events, but this can be minimized with control of blood glucose levels and other risk factors (blood
More informationAn on-line work scheduling and ward requesting pattern information system
Annals of Clinical Biochemistry, 1978, 15, 235-240 An on-line work scheduling and ward requesting pattern information system P. E. UNDRILL AND P. GIBSON From the Department of Chemical Pathology, University
More informationOur Fee for Service Patient Price. Self Pay Price Elsewhere
DPC Services & Savings - February 2019 Mind & Body Christian Health Group, LLC Appointment Types Reason for the Appointment Service Patient s Out of Network General Adult Annual Physical (60 minute face
More informationFrench Creek Software, Inc. Quick Start Guide
French Creek Software, Inc Quick Start Guide Inside This Guide Section 1: Setup - Overview & Install 4 Software Overview System Requirements 5 Installation Section 2: Getting Around - Get to Modeling 7
More informationApplications of Reagents
Applications of Reagents Parameter Reagent Application Acid capacity Ks4.3 ALKA-M-PHOTOMETER Acid concentration Alkalinity-m Alkalinity-p ACID CONCENTRATION ALKA-M-PHOTOMETER ALKA-P-PHOTOMETER Aluminium
More informationCerner 2015 Upgrade. Tagging. Tagging via the Table of Contents
Cerner 2015 Upgrade This document will demonstrate how to utilize the tagging feature, favorite a note template and carbon copy/forward to a provider a progress note as part of the Cerner 2015 upgrade.
More informationUser Definable Settings
User Definable Settings Section 1: User Definable Print Format Settings...1 Section 2: Parameter Unit Selection...7 Section 3: Setup Menu 2...8 Section 4: Setup Menu 3...11 Section 1: User Definable Print
More informationConditional Logic in Templates A Tutorial Revised 6/11/ , 2006 by Donald T. Stewart, MD
Conditional Logic in Templates A Tutorial Revised 6/11/06 2005, 2006 by Donald T. Stewart, MD Introduction: Conditional logic is something that can easily be confusing. The documentation in Practice Partner
More informationExamining Rescue Studies
White Paper Examining Rescue Studies Introduction The purpose of this White Paper is to define a Rescue Study, outline the basic assumptions, including risks, in setting up such a trial based on DATATRAK
More informationUser Guide Chronic Disease Management Tariffs e-form
User Guide Chronic Disease Management Tariffs e-form Page 1 of 15 Table of Contents Computer Requirements... 3 Accessing the e-form... 3 Are eforms Secure?... 4 Completing the Chronic Disease Management
More informationSCHEDULE AN APPOINTMENT
SCHEDULE AN APPOINTMENT 1. Go to https://www.donorpoint.org/. You will be directed to this page. 2. Enter your login information. Enter your username and password. 3. From the login page, you will be directed
More informationTrial Cost Analysis Trial: Knee Surgery Study Sponsor: Principal Investigator: Hillary Resendes Total Enrollment: 8
Total Site Resources Available Coordinator Rate = $50.00 CRA Rate = $45.00 Investigator Rate = $300.00 Site Director Rate = $65.00 Trial Participation Fees Administration Institutional IT Fee $500.00 IRB
More informationNETMED STANDARD PRACTICES. General Technical Support Before calling or ing for technical support please do the following:
NETMED STANDARD PRACTICES General Technical Support Before calling or emailing for technical support please do the following: 1. Restart your computer and see if that fixes the problem. 2. Make sure you
More information